杨继明,程杭,马敏,张伟超,吴勇,任江平,郭建新.左侧乳腺癌患者根治术后常规调强计划与电子束适形联合调强计划的剂量比较[J].中华放射医学与防护杂志,2022,42(4):262-268
左侧乳腺癌患者根治术后常规调强计划与电子束适形联合调强计划的剂量比较
Dosimetric comparison between conventional IMRT and EBCRT combined with IMRT for post-mastectomy left-sided breast cancer patients
投稿时间:2021-12-09  
DOI:10.3760/cma.j.cn112271-20211209-00477
中文关键词:  乳腺癌|根治术|电子束适形放疗|调强放疗|剂量学
英文关键词:Breast cancer|Post-mastectomy|Electron beam conformal radiotherapy|Intensity modulated radiotherapy|Dosimetry
基金项目:余姚市医疗卫生科技计划平台项目(2021YPT02)
作者单位E-mail
杨继明 宁波市第一医院放化疗中心, 宁波 315000  
程杭 浙江省余姚市人民医院放疗技术科, 宁波 315400  
马敏 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科, 北京 100021  
张伟超 河南省滑县人民医院放疗科, 安阳 456400  
吴勇 贵州省兴义市人民医院放疗科, 兴义 562400  
任江平 宁波市第一医院放化疗中心, 宁波 315000  
郭建新 宁波市第一医院放化疗中心, 宁波 315000 gjx1696@yeah.net 
摘要点击次数: 2428
全文下载次数: 664
中文摘要:
      目的 比较左侧乳腺癌患者根治术后常规调强放射治疗计划(intensity modulated radiotherapy,IMRT)与电子束适形放疗(electron beam conformal radiotherapy,EBCRT)联合调强放疗计划的剂量学差异。方法 选择2018年6月至2021年10月于宁波市第一医院放化疗中心收治的20例左侧乳腺癌根治术后患者资料,计划靶区(plan target volume,PTV)包括锁骨上下淋巴结引流区域计划靶区(PTVsc)和患侧胸壁计划靶区(PTVcw),处方剂量均为50 Gy/25次。所有患者均采用美国Varian Eclipse治疗计划系统(treatment planning system,TPS)设计两种放疗计划,然后对比两种放疗计划的剂量学参数差异。结果 所有20例患者的IMRT计划全部满足临床要求,与此同时EBCRT联合IMRT计划中有2例患者因患侧肺剂量参数超出本单位的剂量限定标准而不被临床接受,两例失败计划的胸壁最大深度分别为3.7和4.4 cm,使用的电子束能量分别为12和15 MeV。其余18例患者的胸壁深度均≤3 cm,使用9 MeV及以下能量电子束进行EBCRT联合IMRT计划设计,靶区和各危及器官剂量均满足临床要求,并与IMRT计划进行剂量学配对比较。常规IMRT的均匀性指数(HI)均优于EBCRT联合IMRT计划(tPTVsc=-10.20、tPTVcw=-9.24,P<0.05);常规IMRT整体靶区适形指数(CI)与EBCRT联合IMRT计划比较差异有统计学意义(tPTVall=10.39,P<0.05)。对于危及器官(organ at risk,OARs),EBCRT联合IMRT计划患侧肺的V5 GyV20 GyDmean均较IMRT更低,差异有统计学意义(t=5.98、6.30、11.30,P<0.05);心脏的V25 GyDmean分别降低了8.3%和4.79 Gy (t=15.23、15.76,P< 0.05);冠状动脉左前降支(left anterior descending coronary artery,LADCA)的Dmean降低了44.03%(t=11.69,P<0.05);健侧乳腺的V5 GyDmean分别降低了7.9%和0.8 Gy (t=3.66、4.932 P<0.05);其他OARs剂量差异均无统计学意义(P>0.05)。结论 对于胸壁靶区深度≤3 cm的左侧乳腺癌根治术后患者,EBCRT联合IMRT能显著降低心脏、患侧肺和健侧乳腺的剂量,有利于降低乳腺癌放疗远期并发症风险以进一步提高患者的长期总生存率。而对于胸壁较厚的患者,选择IMRT计划可满足临床要求。
英文摘要:
      Objective To investigate the dosimetric differences between conventional IMRT and electron beam conformal radiotherapy (EBCRT) combined with IMRT for post-mastectomy left-sided breast cancer patients.Methods A total of 20 post-mastectomy left-sided breast cancer patients who were treated in the Ningbo First Hospital from June 2018 to October 2021 were retrospectively studied. The planning target volume (PTV) included the supra-and infra-clavicular regions(PTVsc) and the ipsilateral chest wall (PTVcw), and the prescribed dose was 50 Gy/25 f. All radiotherapy plans were designed using the Varian Eclipse treatment planning system (TPS). After that, the dose distribution of the target volume and the dose exposure of organs at risk (OARs) were compared and analyzed.Results All the IMRT plans met the clinical requirements, yet 2/20 of the EBCRT combined with IMRT plans were not clinically accepted. For these two patients, the maximum chest wall thickness was 3.7 cm and 4.4 cm each, and the designed electron beam energy was 12 MeV and 15 MeV, respectively. The dose to the ipsilateral lung of these two patients exceeded the institution-specific dose limit standard. For the remaining 18 patients whose chest wall thickness was 3 cm or less, the designed electron beams were 9 MeV or less. All the EBCRT combined with IMRT plans were clinically accepted. The target dose distribution of the conventional IMRT was better than that of the EBCRT combined with IMRT (uniformity index (HI):PTVsc:t=-10.20, P<0.05; PTVcw:t=-9.24, P<0.05; conformal index (CI):PTVall:t=10.39, P <0.05). For OARs, the V5 Gy, V20 Gy, and Dmean of the ipsilateral lung of EBCRT combined with IMRT were lower than those of IMRT (t=5.98, 6.30, 11.30, P <0.05). Specifically, the V25 Gy and Dmean of heart decreased by 8.3% and 4.79 Gy, respectively (t=15.23, 15.76, P<0.05), the Dmean of the left anterior descending coronary artery (LADCA) decreased by 44.03% (t=11.69, P <0.05), and the V5 Gy and Dmean of the contralateral breast decreased by 7.9% and 0.8 Gy, respectively (t=3.66, 4.93, P<0.05). The dosimetric differences of other OARs were not statistically significant (P > 0.05).Conclusions For post-mastectomy left-sided breast cancer patients with a chest wall thickness of less than 3 cm, EBCRT combined IMRT can significantly reduce the exposure dose to the heart, the ipsilateral lung, and the contralateral breast, which is beneficial to reducing the potential risk of long-term complications after radiotherapy and can further improve the long-term overall survival rate of patients. For patients with thick chest wall, IMRT plans are more technologically ideal.
HTML  查看全文  查看/发表评论  下载PDF阅读器
关闭